| x | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|---|--------------------------------------------------------------------------------------|

| FOR THE FISCAL YEAR ENDED DECEMBER 31, 2010 |
|---------------------------------------------|

| o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|---|------------------------------------------------------------------------------------------|

| Delaware                                                      |   | 20-5655648                           |
|---------------------------------------------------------------|--------|--------------------------------------|
| (State or other jurisdictionof incorporation or organization) |   | (I.R.S. Employer Identification No.) |

| Large accelerated filer  o | Accelerated filer o | Non-accelerated filer o                                                     | Smaller reporting company x |
|------------------------------------------------|-------------------------------|----------------------------------------------------------------------------------|--------------------------------------------|
|                                           |                          | (Do not check if a smaller reporting company) |                                       |

----

|                        |                                                                                                               |   | Page |
|-----------------------------|--------------------------------------------------------------------------------------------------------------------|--------|------|
| PART I                      |                                                                                                               |   | 1    |
| Forward-looking Information |                                                                                                               | 1      |
| ITEM 1.                     | BUSINESS                                                                                                           |   | 1    |
| ITEM 1A.                    | RISK FACTORS                                                                                                       |   | 4    |
| ITEM 1B                     | UNRESOLVED STAFF COMMENTS                                                                                          |   | 8    |
| ITEM 2.                     | PROPERTIES                                                                                                         |   | 8    |
| ITEM 3.                     | LEGAL PROCEEDINGS                                                                                                  |   | 8    |
| ITEM 4.                     | [REMOVED AND RESERVED]                                                                                             |   | 8    |
|                        |                                                                                                               |   |
| PART II                     |                                                                                                               | 8      |
| ITEM 5.                     | MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES |   | 8    |
| ITEM 6.                     | SELECTED FINANCIAL DATA                                                                                            |   | 9    |
| ITEM 7.                     | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS                   |   | 9    |
| ITEM 7A.                    | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK                                                         |   | 11   |
| ITEM 8.                     | FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA                                                                        |   | 12   |
| ITEM 9.                     | CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE                               |   | 27   |
| ITEM 9A.                    | CONTROLS AND PROCEDURES                                                                                            |   | 27   |
|                        |                                                                                                               |   |
| PART III                    |                                                                                                               | 28     |
| ITEM 10.                    | DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE                                                             |   | 28   |
| ITEM 11.                    | EXECUTIVE COMPENSATION                                                                                             |   | 30   |
| ITEM 12.                    | SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS                     |   | 32   |
| ITEM 13.                    | CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE                                          |   | 34   |
| ITEM 14.                    | PRINCIPAL ACCOUNTING FEES AND SERVICES                                                                             |   | 36   |
|                        |                                                                                                               |   |
| PART IV                     |                                                                                                               | 37     |
|                        |                                                                                                               |   |
| SIGNATURES                  |                                                                                                               | 40     |

----

| ·   | discuss our future expectations; |
|--------------------|----------------------------------|

| ·   | contain projections of our future results of operations or of our financial condition; and |
|--------------------|--------------------------------------------------------------------------------------------|

| ·   | state other “forward-looking” information. |
|--------------------|--------------------------------------------------------|

----

----

| ·   | food production; and |
|--------------------|----------------------|

| ·   | pharmaceutical companies. |
|--------------------|---------------------------|

| ·   | obtaining research and development grants; |
|--------------------|--------------------------------------------|

| ·   | filing and obtaining additional patents; |
|--------------------|------------------------------------------|

| ·   | entering into licensing, marketing or joint venture agreements; |
|--------------------|-----------------------------------------------------------------|

| ·   | applying the olfaction intellectual property to a commercially viable product; |
|--------------------|--------------------------------------------------------------------------------|

| ·   | developing and implementing a marketing plan in conjunction with a partner or licensee; |
|--------------------|-----------------------------------------------------------------------------------------|

| ·   | controlling quality and cost in the manufacturing process in conjunction with a partner or licensee; |
|--------------------|------------------------------------------------------------------------------------------------------|

| ·   | selling products on a profitable basis in conjunction with a partner or licensee; and |
|--------------------|---------------------------------------------------------------------------------------|

| ·   | structuring an agreement that will enable us to enjoy the profits of our products. |
|--------------------|------------------------------------------------------------------------------------|

----

----

----

----

----

| ITEM 5.   | MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES. |
|---------------------|---------------------------------------------------------------------------------------------------------------------|

|           |   | Price  |   |
|----------------|--------|--------|--------|
| Period         |   | High   |   |   | Low |   |
| 2010           |   |   |   |   |   |   |
| First Quarter  |   | $      | 0.04   |   |   | $ | 0.02 |   |
| Second Quarter |   | $      | 0.15   |   |   | $ | 0.01 |   |
| Third Quarter  |   | $      | 0.50   |   |   | $ | 0.05 |   |
| Fourth Quarter |   | $      | 1.55   |   |   | $ | 0.28 |   |
| 2009           |   |   |   |   |   |   |
| First Quarter  |   | $      | 0.13   |   |   | $ | 0.02 |   |
| Second Quarter |   | $      | 0.02   |   |   | $ | 0.02 |   |
| Third Quarter  |   | $      | 0.03   |   |   | $ | 0.02 |   |
| Fourth Quarter |   | $      | 0.10   |   |   | $ | 0.03 |   |

----

| ITEM 7.   | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. |
|---------------------|---------------------------------------------------------------------------------------------------|

----

----

----

|                                                    |   | Page No. |   |
|---------------------------------------------------------|--------|----------|--------|
| Report of Independent Registered Public Accounting Firm |   |     | 13     |   |
|                                                    |   |     |   |   |
| Financial Statements:                                   |   |     |   |   |
|                                                    |   |     |   |   |
| Balance Sheets                                          |   |     | 14     |   |
|                                                    |   |     |   |   |
| Statements of Operations                                |   |     | 15     |   |
|                                                    |   |     |   |   |
| Statements of Changes in Stockholders’ Deficiency |   |     | 16     |   |
|                                                    |   |     |   |   |
| Statements of Cash Flows                                |   |     | 17     |   |
|                                                    |   |     |   |   |
| Notes to Financial Statements                           |   |     | 18     |   |

----

----

| SENTISEARCH, INC. |
|-------------------|
| Balance Sheets    |

| ASSETS                                                                                                                                                     |
|------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                                       |   | December 31, |   |   | December 31, |   |
|                                                                                                                                                       |   | 2010 |   |   | 2009 |   |
| Current Assets                                                                                                                                             |   |   |   |   |   |   |
| Cash and cash equivalents                                                                                                                                  |   | $ | 171,854 |   |   | $ | 73,612 |   |
| Account receivable                                                                                                                                         |   |   | 15,000 |   |   |   | - |   |
| Security deposit                                                                                                                                           |   |   | 4,170 |   |   |   | 4,170 |   |
| Prepaid expense                                                                                                                                            |   |   | 1,236 |   |   |   | - |   |
| Total Current Assets                                                                                                                                       |   |   | 192,260 |   |   |   | 77,782 |   |
|                                                                                                                                                       |   |   |   |   |   |   |   |   |
| Other Assets                                                                                                                                               |   |   |   |   |   |   |   |   |
| Account receivable                                                                                                                                         |   |   | 265,000 |   |   |   | - |   |
| License and patent costs                                                                                                                                   |   |   | 560,325 |   |   |   | 553,332 |   |
| Less: accumulated amortization                                                                                                                             |   |   | (560,325 | ) |   |   | (517,410 | ) |
| Total Other Assets                                                                                                                                         |   |   | 265,000 |   |   |   | 35,922 |   |
|                                                                                                                                                       |   |   |   |   |   |   |   |   |
| Total Assets                                                                                                                                               |   | $ | 457,260 |   |   | $ | 113,704 |   |
|                                                                                                                                                       |   |   |   |   |   |   |   |   |
| LIABILITIES AND STOCKHOLDERS' DEFICIENCY                                                                                                                   |
| Current Liabilities                                                                                                                                        |   |   |   |   |   |   |   |   |
| Accounts payable and accrued expenses                                                                                                                      |   | $ | 144,706 |   |   | $ | 206,149 |   |
| Deferred revenue                                                                                                                                           |   |   | 390,000 |   |   |   | - |   |
| Convertible notes payable - related parties                                                                                                                |   |   | - |   |   |   | 150,000 |   |
| Convertible note payable                                                                                                                                   |   |   | - |   |   |   | 50,000 |   |
| Notes payable - related parties                                                                                                                            |   |   | 70,000 |   |   |   | - |   |
| Total Current Liabilities                                                                                                                                  |   |   | 604,706 |   |   |   | 406,149 |   |
|                                                                                                                                                       |   |   |   |   |   |   |   |   |
| Other Liabilities                                                                                                                                          |   |   |   |   |   |   |   |   |
| Deferred revenue                                                                                                                                           |   |   | 276,250 |   |   |   | - |   |
| Notes payable - related parties                                                                                                                            |   |   | 80,000 |   |   |   | - |   |
| Total other Liabilities                                                                                                                                    |   |   | 356,250 |   |   |   | - |   |
| Total Liabilities                                                                                                                                          |   |   | 960,956 |   |   |   | 406,149 |   |
|                                                                                                                                                       |   |   |   |   |   |   |   |   |
| Commitments and Contingencies                                                                                                                              |   |   | - |   |   |   | - |   |
|                                                                                                                                                       |   |   |   |   |   |   |   |   |
| Stockholders' Deficiency                                                                                                                                   |   |   |   |   |   |   |   |   |
| Common stock — $0.0001 par value, 20,000,000 shares authorized; 16,821,787 and 12,747,844 shares issued and outstanding, respectively |   |   | 1,682 |   |   |   | 1,275 |   |
| Additional paid-in capital                                                                                                                                 |   |   | 2,376,987 |   |   |   | 1,963,415 |   |
| Accumulated deficit                                                                                                                                        |   |   | (2,882,365 | ) |   |   | (2,257,135 | ) |
|                                                                                                                                                       |   |   |   |   |   |   |   |   |
| Total Stockholders' Deficiency                                                                                                                             |   |   | (503,696 | ) |   |   | (292,445 | ) |
|                                                                                                                                                       |   |   |   |   |   |   |   |   |
| Total Liabilities and Stockholders' Deficiency                                                                                                             |   | $ | 457,260 |   |   | $ | 113,704 |   |

| See notes to financial statements. |
|------------------------------------|

----

| SENTISEARCH, INC.        |
|--------------------------|
| Statements of Operations |

|                                               |   | For the yearsEnded December 31, |       |
|----------------------------------------------------|--------|---------------------------------|------------|
|                                               |   | 2010                            |       |   | 2009 |   |
|                                               |   |                            |       |   |   |   |
| Revenues                                           |   | $                               | 113,750    |   |   | $ | - |   |
| Operating expenses:                                |   |                            |       |   |   |   |   |   |
| General and administrative                         |   |                            | 691,612    |   |   |   | 374,344 |   |
| Amortization of license and patent costs           |   |                            | 42,915     |   |   |   | 91,343 |   |
|                                               |   |                            |       |   |   |   |   |   |
|                                               |   |                            | 734,527    |   |   |   | 465,687 |   |
| Net Loss Before Other (Income) Expenses            |   |                            | (620,777   | ) |   |   | (465,689 | ) |
| Other (income) expense:                            |   |                            |       |   |   |   |   |   |
| Interest income                                    |   |                            | (10        | ) |   |   | (498 | ) |
| Interest and financing expense                     |   |                            | 4,463      |   |   |   | 1,540 |   |
|                                               |   |                            | 4,453      |   |   |   | 1,042 |   |
|                                               |   |                            |       |   |   |   |   |   |
| Net loss before provision for                      |   |                            |       |   |   |   |   |   |
| income taxes                                       |   |                            | (625,230   | ) |   |   | (466,729 | ) |
|                                               |   |                            |       |   |   |   |   |   |
| Income taxes                                       |   |                            | -          |   |   |   | - |   |
|                                               |   |                            |       |   |   |   |   |   |
| Net loss                                           |   | $                               | (625,230   | ) |   | $ | (466,729 | ) |
|                                               |   |                            |       |   |   |   |   |   |
| Basic Earnings Per Share                           |   | $                               | (0.04      | ) |   | $ | (0.04 | ) |
| Diluted Earnings Per Share                         |   | $                               | (0.04      | ) |   | $ | (0.04 | ) |
|                                               |   |                            |       |   |   |   |   |   |
|                                               |   |                            |       |   |   |   |   |   |
| Weighted average shares outstanding - basic   |   |                            | 15,739,123 |   |   |   | 12,747,844 |   |
| Weighted average shares outstanding - diluted |   |                            | 15,739,123 |   |   |   | 12,747,844 |   |

| See notes to financial statements. |
|------------------------------------|

----

| SENTISEARCH, INC.                                 |
|---------------------------------------------------|
| Statements of Changes in Stockholders' Deficiency |

|                                                      |   | Common Stock |       |   | Additional Paid-in |   |   | Accumulated |   |   |      |   |
|-----------------------------------------------------------|--------|--------------|------------|--------|--------------------|--------|--------|-------------|--------|--------|-----------|--------|
|                                                      |   | Shares       |       |   | Amount             |   |   | Capital     |   |   | Deficit   |   |   | Total |   |
| Balance - January 1, 2009                                 |   |         | 12,747,844 |   |               | $      | 1,275  |        |   | $      | 1,955,791 |   |   | $ | (1,790,406 | ) |   | $ | 166,660 |   |
| Stock-based compensation expense                          |   |         | -          |   |               |   | -      |        |   |   | 7,624     |   |   |   | - |   |   |   | 7,624 |   |
| Net loss                                                  |   |         | -          |   |               |   | -      |        |   |   | -         |   |   |   | (466,729 | ) |   |   | (466,729 | ) |
| Balance - December 31, 2009                               |   |         | 12,747,844 |   |               | $      | 1,275  |        |   | $      | 1,963,415 |   |   | $ | (2,257,135 | ) |   | $ | (292,445 | ) |
| Issuance of common stock for convertible promissory notes |   |         | 4,073,943  |   |               |   | 407    |        |   |   | 203,290   |   |   |   | - |   |   |   | 203,697 |   |
| Stock-based compensation expense                          |   |         | -          |   |               |   | -      |        |   |   | 210,282   |   |   |   | - |   |   |   | 210,282 |   |
| Net loss                                                  |   |         | -          |   |               |   | -      |        |   |   | -         |   |   |   | (625,230 | ) |   |   | (625,230 | ) |
| Balance - December 31, 2010                               |   |         | 16,821,787 |   |               | $      | 1,682  |        |   | $      | 2,376,987 |   |   | $ | (2,882,365 | ) |   | $ | (503,696 | ) |

|  See notes to financial statements. |
|------------------------------------------|

----

| SENTISEARCH, INC.        |
|--------------------------|
| Statements of Cash Flows |

|                                                                                                                             |   | For the     |     |
|----------------------------------------------------------------------------------------------------------------------------------|--------|-------------|----------|
|                                                                                                                             |   | Year ended  |     |
|                                                                                                                             |   | December 31 |     |
|                                                                                                                             |   | 2010        |     |   | 2009 |   |
|                                                                                                                             |   |        |     |   |   |   |
| Cash flows from operating activities                                                                                             |   |        |     |   |   |   |
| Net loss                                                                                                                         |   | $           | (625,230 | ) |   | $ | (466,729 | ) |
| Adjustments to reconcile net loss to net cash used in operating activities:                                                      |   |        |     |   |   |   |   |   |
| Stock-based compensation expense                                                                                                 |   |        | 210,282  |   |   |   | 7,624 |   |
| Amortization                                                                                                                     |   |        | 42,915   |   |   |   | 91,343 |   |
| Deferred Revenue                                                                                                                 |   |        | (113,750 | ) |   |   |   |   |
|                                                                                                                             |   |        |     |   |   |   |   |   |
| Changes in operating assets & liabilities                                                                                    |   |        |     |   |   |   |   |   |
| Increase in account receivable                                                                                                   |   |        | (280,000 | ) |   |   | - |   |
| Increase in prepaid expense                                                                                                      |   |        | (1,236   | ) |   |   | - |   |
| Increase (Decrease) in accounts payable and accrued expenses                                                                     |   |        | (57,746  | ) |   |   | 80,797 |   |
| Increase in deferred revenue                                                                                                     |   |        | 780,000  |   |   |   | - |   |
|                                                                                                                             |   |        |     |   |   |   |   |   |
| Net cash used in operating activities                                                                                            |   |        | (44,765  | ) |   |   | (286,965 | ) |
|                                                                                                                             |   |        |     |   |   |   |   |   |
| Cash flows from investing activities                                                                                             |   |        |     |   |   |   |   |   |
| Investment in patents                                                                                                            |   |        | (6,993   | ) |   |   | (37,610 | ) |
|                                                                                                                             |   |        |     |   |   |   |   |   |
| Net cash used in investing activities                                                                                            |   |        | (6,993   | ) |   |   | (37,610 | ) |
|                                                                                                                             |   |        |     |   |   |   |   |   |
| Cash flows from financing activities                                                                                             |   |        |     |   |   |   |   |   |
| Proceeds of notes payable - related parties                                                                                      |   |        | 150,000  |   |   |   | - |   |
| Proceeds of convertible notes payable                                                                                            |   |        | -        |   |   |   | 200,000 |   |
|                                                                                                                             |   |        |     |   |   |   |   |   |
| Net cash provided by financing activities                                                                                        |   |        | 150,000  |   |   |   | 200,000 |   |
|                                                                                                                             |   |        |     |   |   |   |   |   |
| Increase (Decrease) in cash and cash equivalents                                                                                 |   |        | 98,242   |   |   |   | (124,575 | ) |
| Cash and cash equivalents — beginning of period                                                                       |   |        | 73,612   |   |   |   | 198,187 |   |
|                                                                                                                             |   |        |     |   |   |   |   |   |
| Cash and cash equivalents — end of period                                                                             |   | $           | 171,854  |   |   | $ | 73,612 |   |
|                                                                                                                             |   |        |     |   |   |   |   |   |
| Non-cash from financing activities:                                                                                              |   |        |     |   |   |   |   |   |
| Conversion of convertible notes payable- related parties, convertible note payable, and related accrued interest to common stock |   | $           | 203,697  |   |   | $ | - |   |

|  See notes to financial statements. |
|------------------------------------------|

----

----

| a.     | Cash and Cash Equivalents – Cash and cash equivalents include liquid investments with maturities of three months or less at the time of purchase.  There are no cash equivalents as of the balance sheet date.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |   |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |   |
| b.     | Accounts Receivable - Accounts receivable are recorded at their estimated realizable value after reduction for an allowance for estimated uncollectible accounts.  The allowance for uncollectible accounts is determined primarily through specific identification and evaluation of significant past due amounts, supplemented by an estimate applied to the remaining balance, which is based on historical experience.  Accounts are deemed past due when payment has not been received within the stated time period.  The Company reviews individual past due amounts periodically and writes-off amounts for which all collection efforts are deemed to have been exhausted. At December 31, 2010, no allowance for uncollectible accounts is deemed necessary.                                                                                                                                                                                                                                                      |   |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |   |
| c.     | Concentration of Credit Risk - Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents.  The Company maintains its cash accounts at high quality financial institutions with balances, at times, in excess of federally insured limits. As of December 31, 2010, the Company had no cash balances in excess of the Federal Deposit Insurance Corporation ("FDIC") insurance limit. Management believes that the financial institutions that hold the Company’s deposits are financially sound and therefore pose minimal credit risk. Recent Federal legislation has made permanent the FDIC deposit insurance limit of $250,000 per depositor.                                                                                                                                                                                                                                                                                                      |   |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |   |
| d.     | License and Patent Costs – The costs of intangible assets that are purchased from others for use in research and development activities and that have alternative future uses (in research and development projects or otherwise) are accounted for in accordance with applicable accounting standards. The amortization of those intangible assets used in research and development activities is a research and development cost. However, the costs of intangibles that are purchased from others for a particular research and development project and that have no alternative future uses (in other research and development projects or otherwise) and therefore no separate economic values, are research and development costs at the time the costs are incurred. We determined that the licensing costs arising from our exclusive licensing agreement with The Trustees of Columbia University had alternative future uses. These costs were capitalized and amortized on a straight-line basis through April 2010 (see Notes 4 and 5). |   |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |   |
| e.     | Impairment – Intangible and long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable. A review for impairment includes comparing the carrying value of an asset to an estimate of the undiscounted net future cash inflows over the life of the asset or fair market value. An asset is considered to be impaired when the carrying value exceeds the calculation of the undiscounted net future cash inflows or fair market value. An impairment loss is defined as the amount of the excess of the carrying value over the fair market value of the asset.                                                                                                                                                                                                                                                                                                                                                                          |   |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |   |
| f.     | Estimates – The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |   |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |   |
| g.     | Income Taxes – The Company utilizes the liability method of accounting for income taxes. Under the liability method, deferred tax assets and liabilities are determined based on the differences between the financial reporting basis and the tax basis of the assets and liabilities and are measured using enacted tax rates and laws that will be in effect, when the differences are expected to reverse. An allowance against deferred tax assets is recognized, when it is more likely than not, that such tax benefits will not be realized.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |   |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |   |
|   |  The Company recognizes the financial statement benefit of an uncertain tax position only after considering the probability that a tax authority would sustain the position in an examination. For tax positions meeting a "more-likely-than-not" threshold, the amount recognized in the financial statements is the benefit expected to be realized upon settlement with the tax authority. For tax positions not meeting the threshold, no financial statement benefit is recognized. The Company recognizes interest and penalties, if any, related to uncertain tax positions in income tax expense. As of December 31, 2010, the Company is unaware of any uncertain tax positions.                                                                                                                                                                                                                                                                                                                                                            |   |

----

| h.     | Loss Per Share –Basic loss per share is calculated by dividing net loss by the weighted average number of shares of common stock outstanding. Diluted loss per share include the effects of securities convertible into common stock, consisting of stock options, to the extent such conversion would be dilutive. The assumed exercise of common stock equivalents was not utilized for the year ended December 31, 2010 since the effect would be anti-dilutive. As of December 31, 2010, 1,075,000 options were outstanding of which 1,025,000 were exercisable.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |   |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |   |
| i.     | Fair Value of Financial Instruments – The Company has adopted the accounting standard for fair value measurements, as it applies to its financial statements. This standard defines fair value, outlines a framework for measuring fair value, and details the required disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants at the measurement date in the principal or most advantageous market. The standard establishes a hierarchy in determining the fair value of an asset or liability. The fair value hierarchy has three levels of inputs, both observable and unobservable. The standard requires the utilization of the lowest possible level of input to determine fair value. Level 1 inputs include quoted market prices in an active market for identical assets or liabilities. Level 2 inputs are market data, other than Level 1, that are observable either directly or indirectly. Level 2 inputs include quoted market prices for similar assets or liabilities, quoted market prices in an inactive market, and other observable information that can be corroborated by market data. Level 3 inputs are unobservable and corroborated by little or no market data. The carrying value of current assets and current liabilities approximates fair value due to the short period of time to maturity. The carrying amount of notes payable approximate their fair value, as the current interest rates on such instruments approximates current market rates on similar instruments.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |   |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |   |
| j.     | Stock-Based Compensation– Stock-based compensation expense represents share-based payment awards based upon the grant date fair value estimated in accordance with accounting standards. The Company recognizes compensation expense for stock option awards on a straight-line basis over the requisite service period of the award. Stock-based compensation expense is recognized based upon awards ultimately expected to vest, reduced for estimated forfeitures. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The expected term of stock options represents the average period the stock options are expected to remain outstanding.  The expected stock price volatility for the Company’s stock options was determined by examining the historical volatilities for industry peers for periods that meet or exceed the expected term of the options, using an average of the historical volatilities of the Company’s industry peers, as the Company did not have sufficient trading history for the Company’s common stock. The Company will continue to analyze the historical stock price volatility and expected term assumption as more historical data for the Company’s common stock becomes available. The risk-free interest rate assumption is based on the U.S. Treasury instruments whose term was consistent with the expected term of the Company’s stock options. The expected dividend assumption is based on the Company’s history and expectation of dividend payouts. The Company accounts for its issuances of stock-based compensation to non-employees for services rendered using the measurement date guidelines enumerated in the accounting standards. Accordingly, the value of any awards that were vested and non forfeitable at their date of issuance were measured based on the fair value of the equity instruments at the date of issuance. The non-vested portion of awards that are subject to the future performance of the counterparty are adjusted at each reporting date to their fair values based upon the then current market value of the Company’s stock and other assumptions that management believes are reasonable. The Company believes that the fair value of the stock options issued to non-employees is more reliably measurable than the fair value of the services rendered. The fair value of the stock options granted was calculated using the Black-Scholes option pricing model.  |   |

----

| k.             | Revenue Recognition - The Securities and Exchange Commission's guidance for revenue recognition requires that certain criteria must be met before revenue can be recognized; persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; the fee is fixed or determinable; and collectability is reasonably assured. Revenues from license agreements are recognized over the life of the agreement as they are earned.  Any amounts received prior to satisfying our revenue recognition criteria are recorded as deferred revenue in the accompanying balance sheets. |   |
|----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |   |
|  l.  | Recently Adopted and Issued Accounting Pronouncements                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |   |
|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |   |
|           | In February 2010, the Financial Accounting Standards Board (“FASB”) issued an update to ASC 855, “Subsequent Events”. The Codification does not require significant changes regarding recognition or disclosure of subsequent events, but does require evaluation of subsequent events through the date the financial statements are issued.  The update was effective upon issuance.  The adoption did not have a significant impact on our financial statements.                                                                                                                 |   |

----

----

----

| Stock Options               |   | Shares |      |   | Weighted-AverageExercise Price |   |   | Weighted-AverageRemainingContractual Term (years) |   |   | Weighted-AverageGrant-DateFair Value |   |   | AggregateIntrinsic Value |   |
|-----------------------------|--------|--------|-----------|--------|--------------------------------|--------|--------|---------------------------------------------------|--------|--------|--------------------------------------|--------|--------|--------------------------|--------|
|                        |   |   |      |   |                           |   |   |                                              |   |   |                                 |   |   |                     |   |
| Outstanding at Jan 01, 2009 |   |   | 575,000   |   |                           | $      | 0.19   |                                              |   |   | 8.8                                  |   |   |                     |   |   | $ | - |   |
| Granted                     |   |   | 100,000   |   |                           |   | 0.05   |                                              |   |   |                                 |   |   | $                        | 0.01   |   |   |   |   |   |
| Outstanding at Dec 31, 2009 |   |   | 675,000   |   |                           | $      | 0.17   |                                              |   |   | 8.1                                  |   |   |                     |   |   |   | $ | - |   |
| Exercisable at Dec 31, 2009 |   |   | 541,667   |   |                           | $      | 0.16   |                                              |   |   | 8.0                                  |   |   |                     |   |   |   | $ | - |   |
|                        |   |   |      |   |                           |   |   |                                              |   |   |                                 |   |   |                     |   |   |   |   |   |   |
| Outstanding at Jan 01, 2010 |   |   | 675,000   |   |                           | $      | 0.17   |                                              |   |   | 8.1                                  |   |   |                     |   |   |   | $ | - |   |
| Granted                     |   |   | 800,000   |   |                           |   | 0.28   |                                              |   |   |                                 |   |   | $                        | 0.27   |   |   |   |   |   |
| Cancelled                   |   |   | (400,000  | )      |                           |   | 0.19   |                                              |   |   |                                 |   |   | $                        | 0.07   |   |   |   |   |   |
| Outstanding at Dec 31, 2010 |   |   | 1,075,000 |   |                           | $      | 0.24   |                                              |   |   | 9.0                                  |   |   |                     |   |   |   | $ | 447,750 |   |
| Exercisable at Dec 31, 2010 |   |   | 1,025,000 |   |                           | $      | 0.24   |                                              |   |   | 8.9                                  |   |   |                     |   |   |   | $ | 428,750 |   |

| Range of ExercisePrices |   |   | Remaining NumberOutstanding |      |   | Weighted AverageContractual Life (Years) |   |   | Weighted AverageExercise Price |   |
|-----------------------------------|--------|--------|----------------------------------|-----------|--------|---------------------------------------------------------|--------|--------|------------------------------------------|--------|
|                              |   |   |                             |      |   |                                                    |   |   |                                     |   |   |   |   |
| $0.05 to $0.28                    |   |   |                             | 1,075,000 |   |                                                    |   | 9.0    |                                     |   | $ | 0.24 |   |

----

|                             |   | December 31, |     |
|----------------------------------|--------|--------------|----------|
|                             |   | 2010         |     |   | 2009 |   |
| Net operating loss carryforwards |   | $            | 703,747  |   |   | $ | 538,245 |   |
| Amortization                     |   |         | 101,327  |   |   |   | 100,850 |   |
| Stock-based compensation         |   |         | 99,176   |   |   |   | 15,063 |   |
| Total deferred tax asset         |   |         | 904,250  |   |   |   | 654,158 |   |
| Less: Valuation allowance        |   |         | (904,250 | ) |   |   | (654,158 | ) |
| Net deferred tax assets          |   | $            | -        |   |   | $ | - |   |

----

|                                       |   | For the years endedDecember 31, |     |
|--------------------------------------------|--------|---------------------------------|----------|
|                                       |   | 2010                            |     |   | 2009 |   |
|                                       |   |                            |     |   |   |   |
| At Statutory rates                         |   | $                               | (212,578 | ) |   | $ | (158,688 | ) |
| State income taxes, net of federal benefit |   |                            | (37,514  | ) |   |   | (28,004 | ) |
| Increase in valuation allowance            |   |                            | 250,092  |   |   |   | 186,692 |   |
| Provision for income taxes                 |   | $                               | -        |   |   | $ | - |   |

----

| ITEM 9. | CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE. |
|---------|---------------------------------------------------------------------------------------|

----

| ·   | Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements. |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| Name               |   | Age |   | Position                                                                             |
|--------------------|--------|-----|--------|--------------------------------------------------------------------------------------|
| Joseph K. Pagano   |   | 66  |   | Chief Executive Officer, Secretary, Treasurer and Chairman of the Board of Directors |
| Frederick R. Adler |   | 85  |   | Director                                                                             |
| Erik R. Lundh      |   | 41  |   | Director                                                                             |
| Dean R. Gresk      |   | 48  |   | Director                                                                             |

----

----

| Name and Principal                     |   |   |   | Salary |    |   | Option Awards(1) |   |    | All OtherCompensation |   |   | Total   |   |
|--------------------------------------------------|--------|--------|--------|--------|---------|--------|-----------------------|--------|---------|----------------------------|--------|--------|---------|--------|
| Position                                         |   | Year   |   | ($)    |    |   | ($)                   |   |    | ($)                        |   |   | ($)     |   |
| Joseph K. Pagano                                 |   | 2010   |   |   | — |   |                  |   | 135,450 |                       |   |   | — |   |   |   | 135,450 |   |
| Chief Executive Officer, Secretary and Treasurer |   | 2009   |   |   | — |   |                  |   | — |                       |   |   | — |   |   |   | — |   |

|               |   | Option awards (1) |    |   | Total  |   |
|--------------------|--------|-----------------------------|---------|--------|--------|--------|
| Name               |   | ($)                         |    |   | ($)    |   |
| Frederick R. Adler |   |                        | 27,940  |   |   |   | 27,940 |   |
| Erik R. Lundh      |   |                        | 41,940  |   |   |   | 41,940 |   |
| Dean R. Gresk      |   |                        | — |   |   |   | — |   |

----

| (1) | The amounts in this column represent the dollar amount recognized in accordance with FASB ASC Topic 718 for financial statement reporting purposes with respect to the 2010 fiscal year for the fair value of stock options granted in 2010. Assumptions used in the calculation of these amounts for the 2010 fiscal year are included in Note 7 to our audited financial statements for the 2010 fiscal year included elsewhere herein. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| Name               |   | Title                                                                   |   | Number of Securities |
|--------------------|--------|-------------------------------------------------------------------------|--------|----------------------|
| Joseph K. Pagano   |   | Chief Executive Officer, Secretary, Treasurer and Chairman of the Board |   | 500,000              |
| Erik Lundh         |   | Director                                                                |   | 150,000              |
| Frederick R. Adler |   | Director                                                                |   | 100,000              |

| Plan category                                            |   | (a)Number ofsecurities tobe issueduponexercise ofoutstandingoptions,warrantsand rights |      |   | (b)Weighted- averageexercise price ofoutstandingoptions,warrants and  rights |   |    | (c)Number ofsecuritiesremainingavailable forfutureissuanceunder equitycompensationplans(excludingsecuritiesreflected incolumn (a)) |   |
|---------------------------------------------------------------|--------|-----------------------------------------------------------------------------------------------------------------|-----------|--------|------------------------------------------------------------------------------------------------------------|--------|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
| Equity compensation plans approved by security holders        |   |                                                                                                            | —   |   |                                                                                                       |   | — |                                                                                                                                                        |   |   | — |   |
| Equity compensation plans not approved by security holders(1) |   |                                                                                                            | 1,075,000 |   |                                                                                                       | $      | 0.24    |                                                                                                                                                        |   |   | 1,200,000 |   |
| Total                                                         |   |                                                                                                            | 1,075,000 |   |                                                                                                       | $      | 0.24    |                                                                                                                                                        |   |   | 1,200,000 |   |

----

| (1)  | Column (a) and (b) represent the aggregate shares issuable upon exercise of outstanding five and ten-year stock options granted from May 2007 through September  2010 to an employee of the Company, a consultant to the Company and the officer and directors of the Company. These options expire at various times with the last expiring on September, 2020. |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| ITEM 12. | SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS. |
|----------|-------------------------------------------------------------------------------------------------|

| Name and Address of Beneficial Owner                                      |   | Amount and Nature of Beneficial Ownership |      |          | Percentage ofCommon Stock |   |
|----------------------------------------------------------------------------------------------------|--------|--------------------------------------------------------------------|-----------|---------------|-------------------------------------|--------|
| Joseph K. Pagano                                                                                   |   |                                                               | 2,141,477 | (1)           |                                |   | 12.4 | % |
| 1217 South Flagler Drive, 3rd FloorWest Palm Beach, Florida 33401                                  |   |                                                               |      |          |                                |   |   |   |
|                                                                                               |   |                                                               |      |          |                                |   |   |   |
| Frederick R. Adler                                                                                 |   |                                                               | 2,354,913 | (2)           |                                |   | 13.8 | % |
| 1520 S. Ocean BoulevardPalm Beach, Florida 33480                                         |   |                                                               |      |          |                                |   |   |   |
|                                                                                               |   |                                                               |      |          |                                |   |   |   |
| Erik R. Lundh                                                                                      |   |                                                               | 200,000   | (3)           |                                |   | 1.2% |   |
| c/o Heidrick & StrugglesOne California Street, Ste. 2400San Francisco, CA 94111      |   |                                                               |      |          |                                |   |   |   |
|                                                                                               |   |                                                               |      |          |                                |   |   |   |
| Dean R. Gresk                                                                                      |   |                                                               | 100,000   | (4)           |                                |   | * |   |
| c/o Aspen Signature Properties215 S. MonarchSuite 201Aspen, CO  81611                    |   |                                                               |      |          |                                |   |   |   |
|                                                                                               |   |                                                               |      |          |                                |   |   |   |
| Samuel A. Rozzi                                                                                    |   |                                                               | 2,646,749 | (5)           |                                |   | 15.7 | % |
| c/o Corporate National Realty Inc.135 Crossways Park Drive, Suite 104Woodbury, New York 11797 |   |                                                               |      |          |                                |   |   |   |
|                                                                                               |   |                                                               |      |          |                                |   |   |   |
| The Joseph A. Pagano, Jr. 2007 Trust                                                               |   |                                                               | 1,651,972 |          |                                |   | 9.8 | % |
| 1217 South Flagler Drive, 3rd FloorWest Palm Beach, Florida 33401                                  |   |                                                               |      |          |                                |   |   |   |
|                                                                                               |   |                                                               |      |          |                                |   |   |   |
| Susan Chapman                                                                                      |   |                                                               | 1,287,525 | (6)           |                                |   | 7.7 | % |
| c/o Adler & Co.400 Madison Ave., Suite 7CNew York, NY 10017                               |   |                                                               |      |          |                                |   |   |   |
|                                                                                               |   |                                                               |      |          |                                |   |   |   |
| Longview Partners, L.P.                                                                            |   |                                                               | 1,260,458 | (7)           |                                |   | 7.5 | % |
| c/o Adler & Co.400 Madison Ave. Suite 7CNew York, NY 10017                                |   |                                                               |      |          |                                |   |   |   |
|                                                                                               |   |                                                               |      |          |                                |   |   |   |
| Rosalind Davidowitz                                                                                |   |                                                               | 1,056,372 |          |                                | 6.3    | % |
| 7 Sutton Place SouthLawrence, New York 11559                                                       |   |                                                               |      |          |                                |   |   |
|                                                                                               |   |                                                               |      |          |                                |   |   |   |
| Executive officer and all directors as a group (four persons)                                 |   |                                                               | 4,796,390 | (1)(2) (3)(4) | 26.9                                | %      |

----

| *  | Represents less than 1%. |
|---------|--------------------------|

----

| (1)   | Includes 25,000 shares of Common Stock held of record by the Joseph A. Pagano, Jr. Trust. Also includes 500,000 shares issuable upon the exercise of stock options to purchase shares of our Common Stock that are exercisable within 60 days of March 23, 2011.  Mr. Pagano disclaims beneficial ownership of all shares other than those held in his name. Does not include the shares of Common Stock held of record by The Joseph A. Pagano Jr. 2007 Trust, an irrevocable trust over which Mr. Pagano has no investment control or voting rights. |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2)   | Includes 200,000 shares issuable upon the exercise of stock options to purchase shares of our Common Stock that are exercisable within 60 days of March 23, 2011. |
|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (3)   | Represents shares issuable upon the exercise of stock options to purchase shares of our Common Stock that are exercisable within 60 days of March 23, 2011.  Does not include 2,500 shares held of record by each of Mr. Lundh’s son and daughter. |
|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (4)   | Represents shares issuable upon the exercise of stock options to purchase shares of our Common Stock that are exercisable within 60 days of March 23, 2011. |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (5)   | Includes 150,000 shares held by Scarsdale Limited Partnership, of which Mr. Rozzi is general partner. Mr. Rozzi’s daughter and The Samuel A. Rozzi Grantor Retained Annuity Trust, of which Mr. Rozzi’s daughter is trustee, are the sole limited partners of Scarsdale Limited Partnership. Mr. Rozzi disclaims beneficial ownership of all shares other than those held in his name. |
|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (6)   | Includes the shares held of record by Longview Partners, L.P. (of which Mrs. Chapman is the general partner), 300 shares held in trusts for the benefit of Mrs. Chapman’s children and 26,767 shares held of record by Mrs. Chapman’s spouse. |
|-----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (7)   | Susan Chapman is the general partner of Longview Partners, L.P., which is the registered holder of these shares. Mrs. Chapman is an adult daughter of Frederick R. Adler. |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ITEM 13. | CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE. |
|----------|----------------------------------------------------------------------------|

----

----

|                    |   | December 31, 2009 |    |   | December 31, 2010 |   |
|------------------------------|--------|-----------------------------|---------|--------|-----------------------------|--------|
| (i) Audit Fees          |   | $                           | 35,000  |   |                        | $      | 44,643 |   |
| (ii) Audit Related Fees |   |                        | -       |   |                        |   | - |   |
| (iii) Tax Fees          |   |                        | -       |   |                        |   | - |   |
| (iv) All Other Fees     |   |                        | -  |   |                        |   | -  |   |
|                         |   |                        |    |   |                        |   |   |   |
| Total Fees                   |   | $                           | 35,000  |   |                        | $      | 44,643 |   |

----

| Exhibit |   | Description                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|---------|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 3.1     |   | Certificate of Incorporation of SentiSearch, Inc.(1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 3.1.1   |   | Certificate of Amendment to Certificate of Incorporation of SentiSearch, Inc. dated June 24, 2008, incorporated by reference to Exhibit 3.1 to SentiSearch’s Form 8-K filed on June 26, 2008.                                                                                                                                                                                                                                                                                                                                         |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 3.2     |   | Bylaws of SentiSearch, Inc.(1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 4.1     |   | Specimen Common Stock Certificate of SentiSearch, Inc.(2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 10.1    |   | Exclusive License Agreement dated April 10, 2000 between Sentigen Biosciences, Inc. (formerly known as Sentigen Corp.), and The Trustees of Columbia University in the City of New York.(1)                                                                                                                                                                                                                                                                                                                                                 |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 10.2    |   | Consent to the Assignment to SentiSearch, Inc. of the Exclusive License Agreement dated April 10, 2000 between Sentigen Biosciences, Inc. (formerly known as Sentigen Corp.), and The Trustees of Columbia University in the City of New York: (1) Letter dated September 25, 2006 by Sentigen Biosciences, Inc. requesting consent to assignment of the Exclusive License Agreement, and (2) Letter dated October 17, 2006 by Columbia University granting consent to the assignment of the Exclusive License Agreement.(1) |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 10.3    |   | Separation and Distribution Agreement, dated as of October 10, 2006, between Sentigen Holding Corp. and SentiSearch, Inc.(1)                                                                                                                                                                                                                                                                                                                                                                                                                |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 10.4    |   | Contribution Agreement, dated as of October 10, 2006, between Sentigen Holding Corp. and SentiSearch, Inc.(1)                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 10.5    |   | Patent Assignment, dated October 10, 2006, by Sentigen Holding Corp. to SentiSearch, Inc.(1)                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 10.6    |   | Form of Indemnification Agreement.(1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 10.7    |   | Option Agreement dated May 16, 2007 by and between Erik R. Lundh and SentiSearch, Inc., incorporated by reference to Exhibit 10.1 to SentiSearch’s Form 8-K filed on May 18, 2007.                                                                                                                                                                                                                                                                                                                                                    |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 10.8    |   | Form of Demand Promissory Note, incorporated by reference to Exhibit 10.1 to SentiSearch’s Form 8-K filed on June 22, 2007.                                                                                                                                                                                                                                                                                                                                                                                                                |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 10.9    |   | Revolving Credit Note, dated as of March 10, 2008, incorporated by reference to Exhibit 10.1 to SentiSearch’s Quarterly Report on Form 10-Q for the Quarter Ended March 31, 2008.                                                                                                                                                                                                                                                                                                                                                          |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 10.10   |   | Form of Subscription Agreement, incorporated by reference to Exhibit 10.1 to SentiSearch’s Form 8-K filed on June 26, 2008.                                                                                                                                                                                                                                                                                                                                                                                                                |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 10.11   |   | Revolving Credit Note dated as of March 10, 2008, incorporated by reference to Exhibit 10.1 to SentiSearch’s Form 8-K filed on May 15, 2008.                                                                                                                                                                                                                                                                                                                                                                                               |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 10.12   |   | Form of Subscription Agreement, incorporated by reference to Exhibit 10.1 to SentiSearch’s Form 8-K filed on June 26, 2008.                                                                                                                                                                                                                                                                                                                                                                                                                |

----

| 10.13  |   | Sublease dated as of June 16, 2009 between SentiSearch and Muriel Siebert & Co., Inc., incorporated by reference to Exhibit 10.1 to SentiSearch’s Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2009.           |
|--------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                                                                                                                                               |
| 10.14  |   | Subordinated Convertible Promissory Note made by SentiSearch in favor of Samuel Rozzi, incorporated by reference to Exhibit 10.14 to SentiSearch’s Annual Report on Form 10-K for the Fiscal Year Ended December  31, 2009.        |
|   |   |                                                                                                                                                                                                                                               |
| 10.15  |   | Subordinated Convertible Promissory Note made by SentiSearch in favor of Frederick R. Adler, incorporated by reference to Exhibit 10.15 to SentiSearch’s Annual Report on Form 10-K for the Fiscal Year Ended December  31, 2009.  |
|   |   |                                                                                                                                                                                                                                               |
| 10.16  |   | Subordinated Convertible Promissory Note made by SentiSearch in favor of Joseph K. Pagano, incorporated by reference to Exhibit 10.16 to SentiSearch’s Annual Report on Form 10-K for the Fiscal Year Ended December  31, 2009.    |
|   |   |                                                                                                                                                                                                                                               |
| 10.17  |   | Subordinated Convertible Promissory Note made by Sentisearch in favor of Rosalind Davidowitz, incorporated by reference to Exhibit 10.17 to SentiSearch’s Annual Report on Form 10-K for the Fiscal Year Ended December  31, 2009. |
|   |   |                                                                                                                                                                                                                                               |
| 10.18  |   | Stock Option Agreement between SentiSearch and Dean R. Gresk dated as of October 20, 2009, incorporated by reference to Exhibit 10.18 to SentiSearch’s Annual Report on Form 10-K for the Fiscal Year Ended December  31, 2009.    |

| 10.19  |   | Demand Note dated as of August 12, 2010 made by SentiSearch, Inc. in favor of Joseph K. Pagano, incorporated by reference to Exhibit 10.1 to SentiSearch’s Quarterly Report on Form 10-Q for the Quarter Ended June 30, 2010.                                        |
|--------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                                                                                                                                                                       |
| 10.20  |   | Demand Note dated as of August 12, 2010 made by SentiSearch, Inc. in favor of Frederick R. Adler, incorporated by reference to Exhibit 10.1 to SentiSearch’s Quarterly Report on Form 10-Q for the Quarter Ended September  30, 2010.                      |
|   |   |                                                                                                                                                                                                                                                                       |
| 10.21  |   | Demand Note dated as of September 7, 2010 made by SentiSearch, Inc. in favor of Samuel A. Rozzi, incorporated by reference to Exhibit 10.2 to SentiSearch’s Quarterly Report on Form 10-Q for the Quarter Ended September  30, 2010.                       |
|   |   |                                                                                                                                                                                                                                                                       |
| 10.22  |   | 2010 Stock Incentive Plan, incorporated by reference to Exhibit 10.3 to SentiSearch’s Quarterly Report on Form 10-Q for the Quarter Ended September  30, 2010.                                                                                             |
|   |   |                                                                                                                                                                                                                                                                       |
| 10.23  |   | Incentive Stock Option Agreement dated as of September 8, 2010 between Joseph K. Pagano and SentiSearch, Inc., incorporated by reference to Exhibit 10.4 to SentiSearch’s Quarterly Report on Form 10-Q for the Quarter Ended September  30, 2010.         |
|   |   |                                                                                                                                                                                                                                                                       |
| 10.24  |   | Non-Qualified Stock Option Agreement dated as of September 8, 2010 between Joseph K. Pagano and SentiSearch, Inc., incorporated by reference to Exhibit 10.5 to SentiSearch’s Quarterly Report on Form 10-Q for the Quarter Ended September  30, 2010.     |
|   |   |                                                                                                                                                                                                                                                                       |
| 10.25  |   | Non-Qualified Stock Option Agreement dated as of September 8, 2010 between Erik Lundh and SentiSearch, Inc., incorporated by reference to Exhibit 10.6 to SentiSearch’s Quarterly Report on Form 10-Q for the Quarter Ended September  30, 2010.           |
|   |   |                                                                                                                                                                                                                                                                       |
| 10.26  |   | Non-Qualified Stock Option Agreement dated as of September 8, 2010 between Frederick Adler and SentiSearch, Inc., incorporated by reference to Exhibit 10.7 to SentiSearch’s Quarterly Report on Form 10-Q for the Quarter Ended September  30, 2010. |

----

| 10.27 |   | Project Research and Product Development Agreement dated as of September 15, 2010 by and between Bayer CropScience AG and SentiSearch, Inc., incorporated by reference to Exhibit 10.8 to SentiSearch’s Quarterly Report on Form 10-Q for the Quarter Ended September  30, 2010. † |
|-------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 10.28  |   | Amendment to License Agreement dated as of January 30, 2011 by and between The Trustees of Columbia University in the City of New York and SentiSearch, Inc., as the successor-in-interest to Sentigen Corp., incorporated by reference to Exhibit 10.1 to SentiSearch’s Form 8-K filed on February 11, 2011. |
|--------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                                                                                                                                                                                                                |
| 31     |   | Certification of Chief Executive and Financial Officer pursuant to Rule 13a-14 and Rule 15d-14(a), promulgated under the Securities and Exchange Act of 1934, as amended.*                                                                                                                                     |
|   |   |                                                                                                                                                                                                                                                                                                                |
| 32     |   | Certification of Chief Executive and Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*                                                                                                                                              |

----

| (1) | Incorporated by reference to SentiSearch’s Registration Statement on Form 10-SB filed with the SEC on November 15, 2006. File No. 000-52320. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | Incorporated by reference to SentiSearch’s Registration Statement on Amendment No. 1 to Form 10-SB filed with the SEC on November 29, 2006. File No. 000-52320. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| *  | Filed herewith |
|---------|----------------|

| † | Portions of this exhibit have been omitted pursuant to a Request for Confidential Treatment and filed separately with the Securities and Exchange Commission.  Such portions are designated “[***]”. |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|                 | SENTISEARCH, INC. |
|----------------------|-------------------|
|                 |              |   |
| Date: March 31, 2011 | By:          | /s/ Joseph K. Pagano |
|                 |              | Joseph K. Pagano,Chief Executive Officer(Principal Executive Officer) |

| Name                   |         | Title                                                                                           |   | Date           |
|------------------------|--------------|-------------------------------------------------------------------------------------------------|--------|----------------|
|                   |         |                                                                                            |   |           |
| /s/ Joseph K. Pagano   |         | Chief Executive Officer, Secretary and Treasurer                                                |   | March 31, 2011 |
| Joseph K. Pagano       |    | Chairman of the Board, Principal ExecutiveOfficer and Principal Financial and AccountingOfficer |   |           |
|                   |         |                                                                                            |   |           |
| /s/ Frederick R. Adler |         | Director                                                                                        |   | March 31, 2011 |
| Frederick R. Adler     |    |                                                                                            |   |           |
|                   |         |                                                                                            |   |           |
| /s/ Dean R. Gresk      |         | Director                                                                                        |   | March 31, 2011 |
| Dean R. Gresk          |    |                                                                                            |   |           |
|                   |         |                                                                                            |   |           |
| /s/ Erik R. Lundh      |         | Director                                                                                        |   | March 31, 2011 |
| Erik R. Lundh          |    |                                                                                            |   |           |

----